NO20012834L - Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus - Google Patents

Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus

Info

Publication number
NO20012834L
NO20012834L NO20012834A NO20012834A NO20012834L NO 20012834 L NO20012834 L NO 20012834L NO 20012834 A NO20012834 A NO 20012834A NO 20012834 A NO20012834 A NO 20012834A NO 20012834 L NO20012834 L NO 20012834L
Authority
NO
Norway
Prior art keywords
carbon atoms
alkyl
perhaloalkyl
aryl
hydrogen
Prior art date
Application number
NO20012834A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012834D0 (no
Inventor
Jonathan David Bloom
Martin Joseph Digrandi
Russel George Dushin
Stanley Albert Lang
Bryan Mark O'hara
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20012834D0 publication Critical patent/NO20012834D0/no
Publication of NO20012834L publication Critical patent/NO20012834L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NO20012834A 1998-12-09 2001-06-08 Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus NO20012834L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20831698A 1998-12-09 1998-12-09
PCT/US1999/028844 WO2000034237A2 (fr) 1998-12-09 1999-12-06 Inhibiteurs des virus de l'herpes a base de thio-urees contenant des acetamides et des acetamides substitues

Publications (2)

Publication Number Publication Date
NO20012834D0 NO20012834D0 (no) 2001-06-08
NO20012834L true NO20012834L (no) 2001-08-07

Family

ID=22774137

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012834A NO20012834L (no) 1998-12-09 2001-06-08 Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus

Country Status (15)

Country Link
EP (1) EP1137633A2 (fr)
JP (1) JP2002531544A (fr)
KR (1) KR20010087413A (fr)
CN (1) CN1333750A (fr)
AU (1) AU3111200A (fr)
BR (1) BR9916041A (fr)
CA (1) CA2350899A1 (fr)
CZ (1) CZ20012060A3 (fr)
EA (1) EA200100640A1 (fr)
HU (1) HUP0104944A3 (fr)
IL (1) IL143204A0 (fr)
NO (1) NO20012834L (fr)
PL (1) PL349131A1 (fr)
WO (1) WO2000034237A2 (fr)
ZA (1) ZA200104142B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
DE60115394T2 (de) 2000-02-29 2006-10-19 Millennium Pharmaceuticals, Inc., Cambridge Benzamide und ähnliche inhibitoren vom faktor xa
CA2503445C (fr) * 2002-10-24 2012-07-31 Merck Patent Gesellschaft Mit Beschraenkter Haftung Derives de methylene uree
US7220768B2 (en) * 2003-02-11 2007-05-22 Wyeth Holdings Corp. Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
AU2004263900A1 (en) 2003-08-08 2005-02-17 Arriva Pharmaceuticals, Inc. Methods of protein production in yeast
US8158814B2 (en) 2003-08-29 2012-04-17 Mitsui Chemicals, Inc. Insecticide for agricultural or horticultural use and method of use thereof
WO2005086915A2 (fr) 2004-03-09 2005-09-22 Arriva Pharmaceuticals, Inc. Traitement de la bronchopneumopathie chronique obstructive par inhalation a faible dose d'inhibiteur de protease
US20100093864A1 (en) * 2006-10-13 2010-04-15 Lica Pharmaceuticals Anti-infective thiourea compounds
ATE544749T1 (de) 2006-11-02 2012-02-15 Millennium Pharm Inc Verfahren zur synthetisierung pharmazeutischer salze aus einem faktor-xa-hemmer
CN108619123A (zh) * 2018-03-13 2018-10-09 武汉威立得生物医药有限公司 Tenovin-1在制备防治人类疱疹病毒感染药物中的应用
WO2019193541A1 (fr) * 2018-04-06 2019-10-10 Glaxosmithkline Intellectual Property Development Limited Dérivés de cycle aromatiques bicycliques de formule (i) utilisés en tant qu'inhibiteurs d'atf4
CN112807294B (zh) * 2019-11-18 2023-09-05 武汉大学 一种酰基硫脲类化合物在制备治疗或预防单纯疱疹病毒i型感染药物中的应用
WO2022150962A1 (fr) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Inhibiteurs de protéase, leur préparation et leurs utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2243370T3 (es) * 1997-04-10 2005-12-01 PHARMACIA & UPJOHN COMPANY LLC Composiciones poliaromaticas para el tratamiento de infecciones por virus herpes.

Also Published As

Publication number Publication date
NO20012834D0 (no) 2001-06-08
AU3111200A (en) 2000-06-26
HUP0104944A2 (hu) 2002-04-29
CN1333750A (zh) 2002-01-30
CZ20012060A3 (cs) 2001-11-14
JP2002531544A (ja) 2002-09-24
BR9916041A (pt) 2001-12-04
PL349131A1 (en) 2002-07-01
IL143204A0 (en) 2002-04-21
ZA200104142B (en) 2002-10-25
CA2350899A1 (fr) 2000-06-15
EP1137633A2 (fr) 2001-10-04
EA200100640A1 (ru) 2001-12-24
WO2000034237A2 (fr) 2000-06-15
HUP0104944A3 (en) 2003-03-28
KR20010087413A (ko) 2001-09-15
WO2000034237A3 (fr) 2000-11-23

Similar Documents

Publication Publication Date Title
NO20012834L (no) Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus
EA200000993A1 (ru) Тризамещенные производные 1,3,5-триазина для лечения вич-инфекционных заболеваний
AU7187981A (en) Aryloxypropanolamines
WO2000034258A3 (fr) Thio-urees a carboxamide heterocyclique inhibitrices des virus de l'herpes et contenant un groupe phenylenediamine
ATE120202T1 (de) Antiherpes-peptidderivate mit einem 1,4-dioxo-c4- n-terminus.
UA50725C2 (uk) Похідні 2-[(2-алкокси-6-трифторметилпіримідин-4-іл)оксиметилен]- фенілоцтової кислоти, спосіб їх отримання, застосування піримідин-4-олів для отримання цих похідних та засіб для боротьби зі шкідниками
WO2005056551A3 (fr) Nouveaux derives du 2-hydroxytetrahydrofuranne et leur application a titre de medicaments
WO2000034261A3 (fr) Inhibiteurs heterocycliques de thio-uree des virus de l'herpes contenant du carboxamide et un groupe phenylenediamine substitue
BG105583A (en) Thiourea as inhibitor of herpes viruses
NO20012837L (no) Tiourea-inhibitorer for herpesvirus
WO2000034260A3 (fr) THIO-UREES α-METHYLBENZYLEES PORTEUSES D'UN GROUPE PHENYLENE-DIAMINE ET INHIBITRICES DES VIRUS DE L'HERPES
DK568088D0 (da) 3,5-dihydroxy-6,8-nonadiensyre-forbindelser og farmaceutiske praeparater indeholdende disse samt 5-hydroxy-3-oxo-6,8-nonadiensyreester-forbindelser til anvendelse som udgangsmateriale ved deres fremstilling
LTIP912A (en) Indenoindole copounds ii, process for preraring them and pharmaceutical composition containing them
BR9916042A (pt) Composto, composição farmacêutica, e, processospara inibir a replicação de um vìrus herpes, e detratamento de um paciente que sofra de umainfecção do vìrus herpes
CA2301967A1 (fr) Derives d'azetidinone pour le traitement d'infections hcmv
CA2301543A1 (fr) Derives d'azetidinone pour le traitement d'infections hcmv
DK0570245T3 (da) Octahydronaphthalenoximderivater til inbibering af kolesterolbiosyntese, deres fremstilling og anvendelse
KR900003165A (ko) 2-아미노-4-모르폴리노-6-프로필-1,3,5-트리아진
ATE168995T1 (de) N-(mercaptoacyl)aminosäure, ihre herstellung, ihre therapeutische verwendung und sie enthaltende pharmazeutische zusammensetzungen
RU2032674C1 (ru) Вещество, обладающее противогерпесным действием
FI953246A (fi) Välituotteet kinoliini-3-karboksyylihappojohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application